Literature DB >> 7376217

Plasma estrone sulfate levels in postmenopausal women.

K D Roberts, J G Rochefort, G Bleau, A Chapdelaine.   

Abstract

Estrone sulfate levels were measured in the plasma of 63 postmenopausal women. The assay method involved prior extraction of the free estrogens, enzyme hydrolysis of the estrone sulfate with sulfatase and radioimmunoassay of the estrone liberated. The plasma levels ranged from 37 to 320 pg/ml (expressed as free estrone) with a mean value of 178 +/- 79 pg/ml. As observed in premenopause, estrone sulfate is quantitatively the most important circulating estrogen in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7376217     DOI: 10.1016/0039-128x(80)90101-4

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  7 in total

1.  SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.

Authors:  Tanda M Dudenkov; James N Ingle; Aman U Buzdar; Mark E Robson; Michiaki Kubo; Irada Ibrahim-Zada; Anthony Batzler; Gregory D Jenkins; Tracy L Pietrzak; Erin E Carlson; Poulami Barman; Matthew P Goetz; Donald W Northfelt; Alvaro Moreno-Aspita; Clark V Williard; Krishna R Kalari; Yusuke Nakamura; Liewei Wang; Richard M Weinshilboum
Journal:  Breast Cancer Res Treat       Date:  2017-04-20       Impact factor: 4.872

Review 2.  Clinical opinion: the biologic and pharmacologic principles of estrogen therapy for symptomatic menopause.

Authors:  Morris Notelovitz
Journal:  MedGenMed       Date:  2006-03-28

3.  Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells.

Authors:  J R Pasqualini; C Gelly; F Lecerf
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

4.  Oestrone sulphate, adipose tissue, and breast cancer.

Authors:  R A Hawkins; M L Thomson; E Killen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide.

Authors:  P E Lønning; D C Johannessen; T Thorsen
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

6.  Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis.

Authors:  Seong Kyu Ahn; Chang Kook Suh; Seok Ho Cha
Journal:  Korean J Physiol Pharmacol       Date:  2015-06-30       Impact factor: 2.016

7.  Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole.

Authors:  G Lunardi; P Piccioli; P Bruzzi; R Notaro; S Lastraioli; M Serra; P Marroni; C Bighin; M Mansutti; F Puglisi; M Porpiglia; R Ponzone; G Bisagni; O Garrone; G Cavazzini; M Clavarezza; L Del Mastro
Journal:  Breast Cancer Res Treat       Date:  2012-11-06       Impact factor: 4.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.